BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lorenzo-Herrero S, López-Soto A, Sordo-Bahamonde C, Gonzalez-Rodriguez AP, Vitale M, Gonzalez S. NK Cell-Based Immunotherapy in Cancer Metastasis. Cancers (Basel) 2018;11:E29. [PMID: 30597841 DOI: 10.3390/cancers11010029] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 10.3] [Reference Citation Analysis]
Number Citing Articles
1 Dianat-Moghadam H, Mahari A, Heidarifard M, Parnianfard N, Pourmousavi-Kh L, Rahbarghazi R, Amoozgar Z. NK cells-directed therapies target circulating tumor cells and metastasis. Cancer Lett 2021;497:41-53. [PMID: 32987138 DOI: 10.1016/j.canlet.2020.09.021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
2 Fortes-Andrade T, Almeida JS, Sousa LM, Santos-Rosa M, Freitas-Tavares P, Casanova JM, Rodrigues-Santos P. The Role of Natural Killer Cells in Soft Tissue Sarcoma: Prospects for Immunotherapy. Cancers (Basel) 2021;13:3865. [PMID: 34359767 DOI: 10.3390/cancers13153865] [Reference Citation Analysis]
3 Park HS, Kim J, Cho MY, Cho YJ, Suh YD, Nam SH, Hong KS. Effectual Labeling of Natural Killer Cells with Upconverting Nanoparticles by Electroporation for In Vivo Tracking and Biodistribution Assessment. ACS Appl Mater Interfaces 2020;12:49362-70. [PMID: 33050704 DOI: 10.1021/acsami.0c12849] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Moro-Pérez L, Lozada-Chang SL, Rivas-García G, Álvarez C, Rojas-Pérez L, Boggiano-Ayo T, González-González Y. Purification and Conformational Characterization of a Novel Interleukin-2 Mutein. Protein J 2021;40:917-28. [PMID: 34643845 DOI: 10.1007/s10930-021-10025-6] [Reference Citation Analysis]
5 Yang S, Cao B, Zhou G, Zhu L, Wang L, Zhang L, Kwok HF, Zhang Z, Zhao Q. Targeting B7-H3 Immune Checkpoint With Chimeric Antigen Receptor-Engineered Natural Killer Cells Exhibits Potent Cytotoxicity Against Non-Small Cell Lung Cancer. Front Pharmacol 2020;11:1089. [PMID: 32848731 DOI: 10.3389/fphar.2020.01089] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
6 Alfarra H, Weir J, Grieve S, Reiman T. Targeting NK Cell Inhibitory Receptors for Precision Multiple Myeloma Immunotherapy. Front Immunol 2020;11:575609. [PMID: 33304346 DOI: 10.3389/fimmu.2020.575609] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
7 Geng J, Wang Y, Zhang L, Wang R, Li C, Sheng W, Li Z, Jiang M. The cajanine derivative LJ101019C regulates the proliferation and enhances the activity of NK cells via Kv1.3 channel-driven activation of the AKT/mTOR pathway. Phytomedicine 2020;66:153113. [PMID: 31790901 DOI: 10.1016/j.phymed.2019.153113] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
8 Shen M, Kang Y. Stresses in the metastatic cascade: molecular mechanisms and therapeutic opportunities. Genes Dev 2020;34:1577-98. [PMID: 33262145 DOI: 10.1101/gad.343251.120] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Crinier A, Vivier E, Bléry M. Helper-like innate lymphoid cells and cancer immunotherapy. Seminars in Immunology 2019;41:101274. [DOI: 10.1016/j.smim.2019.04.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
10 Mattiola I. Immune Circuits to Shape Natural Killer Cells in Cancer. Cancers (Basel) 2021;13:3225. [PMID: 34203391 DOI: 10.3390/cancers13133225] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Karmakar S, Pal P, Lal G. Key Activating and Inhibitory Ligands Involved in the Mobilization of Natural Killer Cells for Cancer Immunotherapies. Immunotargets Ther 2021;10:387-407. [PMID: 34754837 DOI: 10.2147/ITT.S306109] [Reference Citation Analysis]
12 Sordo-Bahamonde C, Lorenzo-Herrero S, Payer ÁR, Gonzalez S, López-Soto A. Mechanisms of Apoptosis Resistance to NK Cell-Mediated Cytotoxicity in Cancer. Int J Mol Sci 2020;21:E3726. [PMID: 32466293 DOI: 10.3390/ijms21103726] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
13 Gossel LDH, Heim C, Pfeffermann LM, Moser LM, Bönig HB, Klingebiel TE, Bader P, Wels WS, Merker M, Rettinger E. Retargeting of NK-92 Cells against High-Risk Rhabdomyosarcomas by Means of an ERBB2 (HER2/Neu)-Specific Chimeric Antigen Receptor. Cancers (Basel) 2021;13:1443. [PMID: 33809981 DOI: 10.3390/cancers13061443] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Raskov H, Orhan A, Salanti A, Gaggar S, Gögenur I. Natural Killer Cells in Cancer and Cancer Immunotherapy. Cancer Lett 2021;520:233-42. [PMID: 34302920 DOI: 10.1016/j.canlet.2021.07.032] [Reference Citation Analysis]
15 Sordo-Bahamonde C, Lorenzo-Herrero S, González S, López-Soto A. A cytofluorimetric assay to evaluate intracellular cytokine production by NK cells. Methods Enzymol 2020;631:343-55. [PMID: 31948556 DOI: 10.1016/bs.mie.2019.05.049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
16 Jo H, Cha B, Kim H, Brito S, Kwak BM, Kim ST, Bin BH, Lee MG. α-Pinene Enhances the Anticancer Activity of Natural Killer Cells via ERK/AKT Pathway. Int J Mol Sci 2021;22:E656. [PMID: 33440866 DOI: 10.3390/ijms22020656] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
17 Thomas R, Al-Khadairi G, Decock J. Immune Checkpoint Inhibitors in Triple Negative Breast Cancer Treatment: Promising Future Prospects. Front Oncol 2020;10:600573. [PMID: 33718107 DOI: 10.3389/fonc.2020.600573] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
18 Vuletić A, Mirjačić Martinović K, Tišma Miletić N, Zoidakis J, Castellvi-Bel S, Čavić M. Cross-Talk Between Tumor Cells Undergoing Epithelial to Mesenchymal Transition and Natural Killer Cells in Tumor Microenvironment in Colorectal Cancer. Front Cell Dev Biol 2021;9:750022. [PMID: 34858978 DOI: 10.3389/fcell.2021.750022] [Reference Citation Analysis]
19 Lin SR, Mokgautsi N, Liu YN. Ras and Wnt Interaction Contribute in Prostate Cancer Bone Metastasis. Molecules 2020;25:E2380. [PMID: 32443915 DOI: 10.3390/molecules25102380] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
20 Sordo-Bahamonde C, Lorenzo-Herrero S, González-Rodríguez AP, Payer ÁR, González-García E, López-Soto A, Gonzalez S. LAG-3 Blockade with Relatlimab (BMS-986016) Restores Anti-Leukemic Responses in Chronic Lymphocytic Leukemia. Cancers (Basel) 2021;13:2112. [PMID: 33925565 DOI: 10.3390/cancers13092112] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
21 Gonzalez-Rodriguez AP, Villa-Álvarez M, Sordo-Bahamonde C, Lorenzo-Herrero S, Gonzalez S. NK Cells in the Treatment of Hematological Malignancies. J Clin Med 2019;8:E1557. [PMID: 31569769 DOI: 10.3390/jcm8101557] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
22 Xu M, Xue B, Wang Y, Wang D, Gao D, Yang S, Zhao Q, Zhou C, Ruan S, Yuan Z. Temperature-Feedback Nanoplatform for NIR-II Penta-Modal Imaging-Guided Synergistic Photothermal Therapy and CAR-NK Immunotherapy of Lung Cancer. Small 2021;:e2101397. [PMID: 34159726 DOI: 10.1002/smll.202101397] [Reference Citation Analysis]
23 Arianfar E, Shahgordi S, Memarian A. Natural Killer Cell Defects in Breast Cancer: A Key Pathway for Tumor Evasion. Int Rev Immunol 2021;40:197-216. [PMID: 33258393 DOI: 10.1080/08830185.2020.1845670] [Reference Citation Analysis]
24 Sanchez-Correa B, Lopez-Sejas N, Duran E, Labella F, Alonso C, Solana R, Tarazona R. Modulation of NK cells with checkpoint inhibitors in the context of cancer immunotherapy. Cancer Immunol Immunother 2019;68:861-70. [PMID: 30953117 DOI: 10.1007/s00262-019-02336-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
25 Rezaeifard S, Talei A, Shariat M, Erfani N. Tumor infiltrating NK cell (TINK) subsets and functional molecules in patients with breast cancer. Mol Immunol 2021;136:161-7. [PMID: 34171565 DOI: 10.1016/j.molimm.2021.03.003] [Reference Citation Analysis]
26 Wang J, Matosevic S. Functional and metabolic targeting of natural killer cells to solid tumors. Cell Oncol 2020;43:577-600. [DOI: 10.1007/s13402-020-00523-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
27 Sanchez-Correa B, Valhondo I, Hassouneh F, Lopez-Sejas N, Pera A, Bergua JM, Arcos MJ, Bañas H, Casas-Avilés I, Durán E, Alonso C, Solana R, Tarazona R. DNAM-1 and the TIGIT/PVRIG/TACTILE Axis: Novel Immune Checkpoints for Natural Killer Cell-Based Cancer Immunotherapy. Cancers (Basel) 2019;11:E877. [PMID: 31234588 DOI: 10.3390/cancers11060877] [Cited by in Crossref: 69] [Cited by in F6Publishing: 60] [Article Influence: 23.0] [Reference Citation Analysis]
28 Sun J, Chen W, Wen B, Zhang M, Sun H, Yang X, Zhao W, La L, An H, Pang J, Gao L, He S. Biejiajian Pill Inhibits Carcinogenesis and Metastasis via the Akt/GSK-3β/Snail Signaling Pathway in Hepatocellular Carcinoma. Front Pharmacol 2021;12:610158. [PMID: 33762939 DOI: 10.3389/fphar.2021.610158] [Reference Citation Analysis]
29 Kupczyk D, Studzińska R, Bilski R, Baumgart S, Kołodziejska R, Woźniak A. Synthesis of Novel 2-(Isopropylamino)thiazol-4(5H)-one Derivatives and Their Inhibitory Activity of 11β-HSD1 and 11β-HSD2 in Aspect of Carcinogenesis Prevention. Molecules 2020;25:E4233. [PMID: 32942682 DOI: 10.3390/molecules25184233] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Sordo-Bahamonde C, Lorenzo-Herrero S, Gonzalez-Rodriguez AP, R Payer Á, González-García E, López-Soto A, Gonzalez S. BTLA/HVEM Axis Induces NK Cell Immunosuppression and Poor Outcome in Chronic Lymphocytic Leukemia. Cancers (Basel) 2021;13:1766. [PMID: 33917094 DOI: 10.3390/cancers13081766] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
31 Han S, Huang K, Gu Z, Wu J. Tumor immune microenvironment modulation-based drug delivery strategies for cancer immunotherapy. Nanoscale 2020;12:413-36. [PMID: 31829394 DOI: 10.1039/c9nr08086d] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
32 Sordo-Bahamonde C, Vitale M, Lorenzo-Herrero S, López-Soto A, Gonzalez S. Mechanisms of Resistance to NK Cell Immunotherapy. Cancers (Basel) 2020;12:E893. [PMID: 32272610 DOI: 10.3390/cancers12040893] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
33 Chugh V, Vijaya Krishna K, Pandit A. Cell Membrane-Coated Mimics: A Methodological Approach for Fabrication, Characterization for Therapeutic Applications, and Challenges for Clinical Translation. ACS Nano 2021. [PMID: 34699181 DOI: 10.1021/acsnano.1c03800] [Reference Citation Analysis]
34 Albini A, Gallazzi M, Palano MT, Carlini V, Ricotta R, Bruno A, Stetler-Stevenson WG, Noonan DM. TIMP1 and TIMP2 Downregulate TGFβ Induced Decidual-like Phenotype in Natural Killer Cells. Cancers (Basel) 2021;13:4955. [PMID: 34638439 DOI: 10.3390/cancers13194955] [Reference Citation Analysis]
35 Arshad U, Sutton PA, Ashford MB, Treacher KE, Liptrott NJ, Rannard SP, Goldring CE, Owen A. Critical considerations for targeting colorectal liver metastases with nanotechnology. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2020;12:e1588. [PMID: 31566913 DOI: 10.1002/wnan.1588] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
36 Chung S, Revia RA, Zhang M. Iron oxide nanoparticles for immune cell labeling and cancer immunotherapy. Nanoscale Horiz 2021;6:696-717. [PMID: 34286791 DOI: 10.1039/d1nh00179e] [Reference Citation Analysis]
37 Song X, Xu C, Wu X, Zhao X, Fan J, Meng S. The potential markers of NK-92 associated to cytotoxicity against K562 cells. Biologicals 2020;68:46-53. [PMID: 32933840 DOI: 10.1016/j.biologicals.2020.08.009] [Reference Citation Analysis]
38 Abulizi A, Shao Y, Aji T, Li Z, Zhang C, Aini A, Wang H, Tuxun T, Li L, Zhang N, Lin R, Wen H. Echinococcus multilocularis inoculation induces NK cell functional decrease through high expression of NKG2A in C57BL/6 mice. BMC Infect Dis 2019;19:792. [PMID: 31500589 DOI: 10.1186/s12879-019-4417-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
39 Liu Y, Zhang Y, Ding Y, Zhuang R. Platelet-mediated tumor metastasis mechanism and the role of cell adhesion molecules. Crit Rev Oncol Hematol 2021;167:103502. [PMID: 34662726 DOI: 10.1016/j.critrevonc.2021.103502] [Reference Citation Analysis]
40 Mu Q, Najafi M. Modulation of the tumor microenvironment (TME) by melatonin. Eur J Pharmacol 2021;907:174365. [PMID: 34302814 DOI: 10.1016/j.ejphar.2021.174365] [Reference Citation Analysis]